Cite
HARVARD Citation
Tang, B. et al. (2022). Allogeneic double‐negative T cell therapy for relapsed acute myeloid leukemia patients post allogeneic hematopoietic stem cell transplantation: A first‐in‐human phase I study. American journal of hematology. 97 (7), pp. E264-E267. [Online].